儿童及青年期诊断的分化型甲状腺癌的长期结局
这项回顾性研究纳入155例20岁及以下诊断的分化型甲状腺癌患者,中位诊断年龄17岁,中位随访16年。末次随访时52.3%患者达 excellent response,疾病特异性死亡率为0%。诊断年龄越小,远处转移和较大肿瘤比例越高,治疗反应越差,提示该人群需长期随访。
要点
- 儿童及青年分化型甲状腺癌长期生存极佳,疾病特异性死亡率为0%。
- 诊断年龄越小,远处转移风险越高且治疗反应越差。
- 随访超过50年的患者中67%出现疾病进展,支持长期随访。
核心结论
- 儿童及青年期诊断的分化型甲状腺癌患者长期生存极佳,但晚年可能出现疾病进展。
- 诊断年龄较小是远处转移和治疗反应较差的危险因素。
研究设计与样本
- 回顾性研究,纳入155例20岁及以下诊断的分化型甲状腺癌患者,中位诊断年龄17岁(9-20岁)。
- 中位随访时间16年(1-63年)。
主要发现
- 末次随访时52.3%患者达 excellent response,疾病特异性死亡率为0%。
- 随访超过50年的9例患者中,中位稳定期36年,6例(67%)出现进展。
临床怎么用
- 对儿童及青年期诊断的分化型甲状腺癌患者应进行长期随访。
- 诊断年龄较小的患者需关注远处转移风险及治疗反应评估。
局限性
- 回顾性研究设计。
- 年龄 cutoff 不一致可能影响可比性(原文提及既往研究局限)。
- 随访超过50年的患者样本量小(n=9)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Rates of pediatric differentiated thyroid cancer (DTC) in the United States have been increasing while studies on this population remain limited by inconsistent age cutoffs, short follow-up periods, or relative lack of clinical data. OBJECTIVE: This work aimed to report long-term outcomes in patients diagnosed with DTC at age 20 years and younger. METHODS: A retrospective study was conducted of patients diagnosed with DTC at age 20 years or younger with long-term follow-up. RESULTS: A total of 155 patients were included with a median age at diagnosis of 17 years (9-20 years). The frequency of distant metastasis and larger tumor size were inversely related to age at diagnosis (overall stage P = .045; T-stage (size of the primary tumor ± invasion); P = .001). The median duration of follow-up was 16 years (1-63 years) and at last follow-up, 52.3% of patients had excellent response and disease specific mortality was 0%. There was no difference in response to therapy based on histologic subtype or birth sex; however, younger age at diagnosis was associated with worse response (P = .046). Patients with more than 50 years of follow-up (n = 9) had a median of 36 years of stability, with progression occurring in 6 out of 9 (67%) patients. CONCLUSION: Patients diagnosed with DTC as children or young adults have outstanding long-term survivorship, but may experience disease progression later in life, suggesting that long-term follow-up might be appropriate for this population. Younger age at diagnosis was identified as a risk factor for distant metastases and poorer response to therapy.
引用
- Valenciaga A, Liyanarachchi S, Brock PL, et al. Long-Term Outcomes of Patients Diagnosed With Differentiated Thyroid Cancer in Childhood and Young Adulthood. J Clin Endocrinol Metab. 2026. PMID: 40973122. doi:10.1210/clinem/dgaf522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。